RAAVEN

Serial Number 79409327
661

Registration Progress

Application Filed
Sep 30, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

RAAVEN

Basic Information

Serial Number
79409327
Filing Date
September 30, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
661
Status Date
Dec 16, 2025
Application
Pending
Classes
042

Rights Holder

Raaven Therapeutics AB

03
Address
Nils Forsbergsgatan 12
SE-217 54 Malmö
SE

Ownership History

Raaven Therapeutics AB

Original Applicant
03
SE

Legal Representation

Attorney
Sara Miller

Application History

12 events
Date Code Type Description Documents
Dec 16, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 16, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 16, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 5, 2025 RFNT P REFUSAL PROCESSED BY IB Loading...
Jun 18, 2025 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jun 18, 2025 RFRR P REFUSAL PROCESSED BY MPU Loading...
Apr 17, 2025 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Apr 16, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 19, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 15, 2024 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Nov 15, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 14, 2024 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 042
Scientific research in the field of gene therapy; biological research, clinical research in the field of gene therapy, and medical research; medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research for medical purposes in the area of cancerous diseases; medical research laboratory services; consultancy relating to scientific research in the field of pharmacogenetics; pharmaceutical research and development; consultancy in the field of pharmaceutical research; platform as a service (PaaS) featuring computer software platforms for use in screening and validation of AAV capsids within gene therapy research.

Classification

International Classes
042